Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Am. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kimman, T. G.
Right arrow Articles by Conyn-van Spaendonck, M. A. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kimman, T. G.
Right arrow Articles by Conyn-van Spaendonck, M. A. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 3 : 217-218
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health

ORIGINAL CONTRIBUTION

The Authors Respond to Hull et al.

Tjeerd G. Kimman1, Hester E. de Melker2, Frithjofna Abbink2, Nazrin Elzinga-Gholizadea3, Ton van Loon4 and Marina A. E. Conyn-van Spaendonck2

1 Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
2 Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
3 Laboratory for Control of Biological Products, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
4 Department of Virology, Eijkman Winkler Institute, University Medical Center Utrecht, Utrecht, the Netherlands.

Abbreviations: IPV, inactivated polio vaccine; OPV, oral polio vaccine; VDPV, vaccine-derived poliovirus


   INTRODUCTION
 
Hull et al. (1Go) raise important issues regarding the eradication of poliovirus and the ending of polio immunization. Our study (2Go) provides generally reassuring data on the immunity of the Dutch population. Nonetheless, it also pinpoints "weak spots": first, the community of people who refuse vaccination for religious reasons; second, the lower seroprevalence among those persons in the general population born before 1945. . . . [Full Text of this Article]


   NOTES
 

   REFERENCES
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Am. J. Epidemiol.:

Immunity to Poliomyelitis in the Netherlands
Marina A. E. Conyn-van Spaendonck, Hester E. de Melker, Frithjofna Abbink, Nazrin Elzinga-Gholizadea, Tjeerd G. Kimman, and Ton van Loon
Am. J. Epidemiol. 2001 153: 207-214. [Abstract] [FREE Full Text]